scholarly journals Singapore's multibillion dollar gamble

2006 ◽  
Vol 203 (5) ◽  
pp. 1139-1142 ◽  
Author(s):  
Heather L. Van Epps
Keyword(s):  
Rhode Island ◽  
Biomedical Research ◽  
Large Dose ◽  
Biomedical Science

Biopolis, Singapore's futuristic research hub. How does a country one-fourth the size of Rhode Island with little history in biomedical science become one of the world's biomedical research giants? The answer: with a pile of money and a large dose of chutzpah. Since 2000, Singapore has dumped more than US$2 billion into developing a biomedical research industry—from scratch. Is the gamble paying off?

scholarly journals Capacity-Building for Career Paths in Public Health and Biomedical Research for Undergraduate Minority Students: A Jackson Heart Study Success Model

2016 ◽  
Vol 26 (3) ◽  
pp. 399 ◽  
Author(s):  
Wendy Brown White ◽  
Asoka Srinivasan ◽  
Cheryl Nelson ◽  
Nimr Fahmy ◽  
Frances Henderson
Keyword(s):  
Public Health ◽  
Minority Students ◽  
Undergraduate Students ◽  
Biomedical Research ◽  
Population Based ◽  
Black College ◽  
Biomedical Science ◽  
Individual Student ◽  
Underrepresented Minority ◽  
Professional Programs

<p><strong>Objective: </strong>This article chronicles the building of individual student capacity as well as faculty and institutional capacity, within the context of a population-based, longitudinal study of African Americans and cardiovascular disease. The purpose of this article is to present preliminary data documenting the results of this approach. <strong></strong></p><p><strong>Design: </strong>The JHS Scholars program is designed, under the organizational structure of the Natural Sciences Division at Tougaloo College, to provide solid preparation in quantitative skills through: good preparation in mathematics and the sciences; a high level of reading comprehension; hands-on learning experiences; and mentoring and counseling to sustain the motivation of the students to pursue further studies. </p><p><strong>Setting: </strong>This program is on the campus of a private Historically Black College in Mississippi. <strong></strong></p><p><strong>Participants: </strong>The participants in the program are undergraduate students. <strong></strong></p><p><strong>Main Outcome Measures: </strong>Data, which included information on major area of study, institution attended, degrees earned and position in the workforce, were analyzed using STATA 14. <strong></strong></p><p><strong>Results: </strong>Of 167 scholars, 46 are currently enrolled, while 118 have graduated. One half have completed graduate or professional programs, including; medicine, public health, pharmacy, nursing, and biomedical science; approximately one-fourth (25.4 %) are enrolled in graduate or professional programs; and nearly one tenth (9.3%) completed graduate degrees in law, education, business or English. </p><p><strong>Conclusions: </strong>These data could assist other institutions in understanding the career development process that helps underrepresented minority students in higher education to make career choices on a path toward public health, health professions, biomedical research, and related careers. <em>Ethn Dis. </em>2016;26(3):399-406; doi:10.18865/ed.26.3.399 </p>

Welcome Note from Editor-in-Chief

2019 ◽  
Vol 1 (2) ◽  
Author(s):  
Prof. Dr. Anna Maria Lavezzi
Keyword(s):  
Biological Sciences ◽  
Biomedical Research ◽  
Cell Biology ◽  
Biomedical Science ◽  
Process Time ◽  
Biomedical Sciences ◽  
High Quality ◽  
Health Initiatives ◽  
Science Domain

It is with great pleasure that I write this editorial to welcome you to the first issue of this new International journal, “Pakistan Biomedical Journal” (PBMJ). The topics covered by the journal are certainly broad and interesting. Biomedical science is a collection of applied sciences that help us understand, research, and innovate within the _eld of healthcare. It includes disciplines like molecular biology, clinical virology, bioinformatics, and biomedical engineering, among others. It's designed to apply the biological sciences to advance not only individual health but also the area of public health. Biomedical Research can help health professions better understand things like the human body and cell biology, making advances in our understanding of epidemics, health initiatives, and human health in the age of longer life expectancy. It aids our understanding of infectious disease and provides research opportunities into some of our most troubling health issues. The journal will continue to publish high quality clinical and biomedical research in health and disease later in life. Peer review will remain a vital component of our assessment of submitted articles. I am very happy to have a team of excellent editors and editorial board members from the top international league covering in depth the related topics. They will ensure the highest standards of quality for the published manuscripts and, at the same time, keep the process time as short as possible. We hope to bring best researches in the _eld of biomedical sciences that may serve as a guideline in health awareness, understanding the mechanisms and its management in future. We definitely look forward to receiving your excellent studies to making PBMJ synonymous with high quality in the biomedical science domain.

scholarly journals The Brazilian Reproducibility Initiative: a systematic assessment of Brazilian biomedical science

2018 ◽  
Author(s):  
Olavo Bohrer Amaral ◽  
Kleber Neves ◽  
Ana Paula Wasilewska-Sampaio ◽  
Clarissa França Dias Carneiro
Keyword(s):  
Biomedical Research ◽  
National Level ◽  
Life Sciences ◽  
Biomedical Science ◽  
Laboratory Methods ◽  
Systematic Assessment ◽  
Interlaboratory Variability ◽  
Systematic Effort ◽  
Common Laboratory

With concerns over research reproducibility on the rise, systematic replications of published science have become an important tool to estimate the replicability of findings in specific areas. Nevertheless, such initiatives are still uncommon in biomedical science, and have never been performed at a national level. The Brazilian Reproducibility Initiative is a multicenter, systematic effort to assess the reproducibility of the country’s biomedical research by replicating between 60 and 100 experiments from Brazilian life sciences articles. The project will focus on a set of common laboratory methods, performing each experiment in multiple institutions across the country, with the reproducibility of published findings analyzed in the light of interlaboratory variability. The results, due in 2021, will allow us not only to estimate the reproducibility of Brazilian biomedical science, but also to investigate if there are aspects of the published literature that can be used to predict it.

Biomedical Research Funding: View of the National Caucus of Basic Biomedical Science Chairs

1992 ◽  
Vol 6 (13) ◽  
pp. 3133-3134 ◽  
Author(s):  
H. George Mandel ◽  
Raymond L. Woosley ◽  
Elliot S. Vesell
Keyword(s):  
Biomedical Research ◽  
Research Funding ◽  
Biomedical Science

Educating Congress on the importance of investigator-initiated biomedical research: Role of individual investigators and professional societies

1994 ◽  
Vol 52 ◽  
pp. 2-3
Author(s):  
B. R. Brinkley
Keyword(s):  
Public Policy ◽  
Biomedical Research ◽  
Cell Biology ◽  
Research Funding ◽  
Political Process ◽  
Biomedical Science ◽  
Blue Ribbon ◽  
The Public ◽  
Active Involvement ◽  
American Society

Although American biomedical science relies heavily on the Federal Government for research funding, individual scientists have traditionally shunned politics and public policy. In years past, scientists were not encouraged to mingle with politicians, most of whom viewed scientists as fuzzballs and eggheads with whom they had little in common. Scientists generally believed that government and society valued their services and would always provide substantial support for research and training. Today, biomedical research funding requires a keen knowledge of the U. S. Congress and the political process. Indeed, our professional survival and that of our students and trainees requires active involvement in Washington politics. We can no longer defer the task of justifying our role in society to institutions or blue ribbon panels of elite science experts. Democratic decision-making at its best is process-oriented, time-consuming, and bottom-up, not top-down. Through its proactive policies involving networking, congressional testimony, education and targeted funding goals, the Public Policy Committee of the American Society for Cell Biology has provided a model strategy for member-oriented commitment to science and public policy.

Social and Ethical Aspects of Biomedical Research

2009 ◽  
pp. 126-144
Author(s):  
Gerrhard Fortwengel
Keyword(s):  
Biomedical Research ◽  
Ethical Issues ◽  
Human Subjects ◽  
Biomedical Science ◽  
Basic Requirement ◽  
Ethical Aspects ◽  
Core Section ◽  
Social And Ethical Issues ◽  
Definition Of ◽  
The Individual

At the beginning of this section the authors provide a definition of biomedical research and an interpretation of the meaning of ethics and social values of research. They continue with the introduction of the risk-benefit approach as basic requirement for any biomedical research involving human subjects and illustrate the need for uniformity with respect to social and ethical issues. The differences and similarities between social and ethical research are described in the core section; social and ethical aspects are presented according to central and peripheral dimensions. In reference to specific areas of research in biomedical science it is exemplary shown that more general principles are not sufficient to cover all types of research, and that depending on research characteristics, the techniques used and the purpose of the research, other specific aspects might need to be considered as well. The chapter ends with a short conclusion calling for continued reflection and review of social and ethical issues speeding an age of fast changes in science and technologies to thereby ensure proper protection of the individual and the best future for society.

scholarly journals Run the Experiment, Publish the Study, Close the Sale: Business, Values, Science and Biomedical Research – A Thematic Introduction

2016 ◽  
Vol 3 (2) ◽  
pp. 5-21
Author(s):  
Aleta Quinn
Keyword(s):  
Biomedical Research ◽  
Business Models ◽  
Business Strategies ◽  
Biomedical Science ◽  
Attribution Of Responsibility ◽  
Values In Science ◽  
Epistemic Values ◽  
Publication Planning ◽  
Methodological Choices

Business models for biomedical research prescribe decentralization due to market selection pressures. I argue that decentralized biomedical research does not match four normative philosophical models of the role of values in science. Non-epistemic values affect the internal stages of for-profit biomedical science. Publication planning, effected by Contract Research Organizations, inhibits mechanisms for transformative criticism. The structure of contracted research precludes attribution of responsibility for foreseeable harm resulting from methodological choices. The effectiveness of business strategies leads to over-representation of profit values versus the values of the general public. These disconnects in respect to the proper role of values in science results from structural issues ultimately linked to the distinct goals of business versus applied science, and so it seems likely that disconnects will also be found in other dimensions of attempts to combine business and science. The volume and integration in the publishing community of decentralized biomedical research imply that the entire community of biomedical research science cannot match the normative criteria of community-focused models of values in science. Several proposals for changing research funding structure might successfully relieve market pressures that drive decentralization.

scholarly journals The millennium bugs

2012 ◽  
Vol 33 (3) ◽  
pp. 119
Author(s):  
Paul R Fisher
Keyword(s):  
Biomedical Research ◽  
Model Organism ◽  
Large Impact ◽  
Biomedical Science ◽  
Model Organisms ◽  
Value For Money ◽  
Scientific Impact ◽  
Cellular Processes ◽  
The Third ◽  
Nobel Prizes

In the first decade of the new millennium, microorganisms continued to have a disproportionately large impact on biomedical science, not so much because they cause disease but because they provide tractable models in which to study fundamental cellular processes. They have featured in Nobel Prizes every year this century except 2004 and 2010. Of the nine non-mammalian model organisms recognised in the first years of the millennium by the NIH for their value in biomedical research, four were microbes. Collectively, a nation?s effort in studying these model organisms correlates more strongly with its worldwide scientific impact than research in other fields. Compared to other fields, research on model organisms generates three to four times more publications per funding dollar and is three to four times more likely to be sufficiently significant for publication in Nature or Science. Given the scientific impact and value for money of model organism research, Australia in the third millennium should invest significantly more funds in this type of research.

scholarly journals Impact of the COVID-19 Pandemic on Cardiovascular Science: Anticipating Problems and Potential Solutions: A Presidential Advisory From the American Heart Association

Circulation ◽  
2021 ◽  
Author(s):  
Elizabeth M. McNally ◽  
Mitchell S.V. Elkind ◽  
Ivor J. Benjamin ◽  
Mina K. Chung ◽  
Glenn H. Dillon ◽  
...  
Keyword(s):  
Clinical Research ◽  
Biomedical Research ◽  
Research Participation ◽  
Heart Association ◽  
Well Being ◽  
Biomedical Science ◽  
Experimental Science ◽  
Research Activity ◽  
Key Steps ◽  
The Impact

The coronavirus disease 2019 (COVID-19) pandemic has had worldwide repercussions for health care and research. In spring 2020, most non–COVID-19 research was halted, hindering research across the spectrum from laboratory-based experimental science to clinical research. Through the second half of 2020 and the first half of 2021, biomedical research, including cardiovascular science, only gradually restarted, with many restrictions on onsite activities, limited clinical research participation, and the challenges associated with working from home and caregiver responsibilities. Compounding these impediments, much of the global biomedical research infrastructure was redirected toward vaccine testing and deployment. This redirection of supply chains, personnel, and equipment has additionally hampered restoration of normal research activity. Transition to virtual interactions offset some of these limitations but did not adequately replace the need for scientific exchange and collaboration. Here, we outline key steps to reinvigorate biomedical research, including a call for increased support from the National Institutes of Health. We also call on academic institutions, publishers, reviewers, and supervisors to consider the impact of COVID-19 when assessing productivity, recognizing that the pandemic did not affect all equally. We identify trainees and junior investigators, especially those with caregiving roles, as most at risk of being lost from the biomedical workforce and identify steps to reduce the loss of these key investigators. Although the global pandemic highlighted the power of biomedical science to define, treat, and protect against threats to human health, significant investment in the biomedical workforce is required to maintain and promote well-being.

Sign in / Sign up

Export Citation Format

Share Document